WallStreetZenWallStreetZen

NASDAQ: TELA
Tela Bio Inc Stock

$8.07-0.13 (-1.59%)
Updated Sep 22, 2023
TELA Price
$8.07
Fair Value Price
N/A
Market Cap
$197.61M
52 Week Low
$6.40
52 Week High
$13.18
P/E
-3.65x
P/B
4.94x
P/S
4.79x
PEG
N/A
Dividend Yield
N/A
Revenue
$49.18M
Earnings
-$43.51M
Gross Margin
68.3%
Operating Margin
-78.81%
Profit Margin
-88.5%
Debt to Equity
1.36
Operating Cash Flow
-$41M
Beta
0.96
Next Earnings
Nov 7, 2023
Ex-Dividend
N/A
Next Dividend
N/A

TELA Overview

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TELA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TELA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TELA is poor value based on its book value relative to its share price (4.94x), compared to the US Medical Devices industry average (3.54x)
P/B vs Industry Valuation
TELA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more TELA due diligence checks available for Premium users.

Be the first to know about important TELA news, forecast changes, insider trades & much more!

TELA News

Valuation

TELA fair value

Fair Value of TELA stock based on Discounted Cash Flow (DCF)
Price
$8.07
Fair Value
$10.45
Undervalued by
22.78%
TELA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TELA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.65x
Industry
49.22x
Market
14.52x

TELA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.94x
Industry
3.54x
TELA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TELA's financial health

Profit margin

Revenue
$14.5M
Net Income
-$10.8M
Profit Margin
-74.4%
TELA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TELA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$94.4M
Liabilities
$54.4M
Debt to equity
1.36
TELA's short-term assets ($89.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TELA's short-term assets ($89.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TELA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$11.3M
Investing
-$157.0k
Financing
$46.4M
TELA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TELA vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
TELA$197.61M-1.59%-3.65x4.94x
MASS$195.30M+0.67%-5.08x1.12x
NPCE$204.03M+1.15%-4.67x9.61x
AXGN$208.47M-2.81%-8.66x2.15x
ALUR$210.66M-9.01%-0.62x-2.37x

Tela Bio Stock FAQ

What is Tela Bio's quote symbol?

(NASDAQ: TELA) Tela Bio trades on the NASDAQ under the ticker symbol TELA. Tela Bio stock quotes can also be displayed as NASDAQ: TELA.

If you're new to stock investing, here's how to buy Tela Bio stock.

What is the 52 week high and low for Tela Bio (NASDAQ: TELA)?

(NASDAQ: TELA) Tela Bio's 52-week high was $13.18, and its 52-week low was $6.40. It is currently -38.77% from its 52-week high and 26.09% from its 52-week low.

How much is Tela Bio stock worth today?

(NASDAQ: TELA) Tela Bio currently has 24,487,451 outstanding shares. With Tela Bio stock trading at $8.07 per share, the total value of Tela Bio stock (market capitalization) is $197.61M.

Tela Bio stock was originally listed at a price of $13.35 in Nov 8, 2019. If you had invested in Tela Bio stock at $13.35, your return over the last 3 years would have been -39.55%, for an annualized return of -15.45% (not including any dividends or dividend reinvestments).

How much is Tela Bio's stock price per share?

(NASDAQ: TELA) Tela Bio stock price per share is $8.07 today (as of Sep 22, 2023).

What is Tela Bio's Market Cap?

(NASDAQ: TELA) Tela Bio's market cap is $197.61M, as of Sep 23, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Tela Bio's market cap is calculated by multiplying TELA's current stock price of $8.07 by TELA's total outstanding shares of 24,487,451.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.